Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1586/14760584.2014.885841 http://scihub22266oqcxt.onion/10.1586/14760584.2014.885841 C4785864!4785864!24575870     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24575870&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Vaccines 2014 ; 13 (4): 521-31 Nephropedia Template TP {{tp|p=24575870|t=2014. Ebola virus vaccines: an overview of current approaches |pdf=|usr=}}{{24575870}} gab.com Text Ebola virus vaccines: an overview of current approaches JO: Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=24575870 #FOAvip Ebola hemorrhagic fever is one of the most fatal viral diseases worldwide affecting humans and nonhuman primates. Although infections only occur frequently in Central Africa, the virus has the potential to spread globally and is classified as a category A pathogen that could be misused as a bioterrorism agent. As of today there is no vaccine or treatment licensed to counteract Ebola virus infections. DNA, subunit and several viral vector approaches, replicating and non-replicating, have been tested as potential vaccine platforms and their protective efficacy has been evaluated in nonhuman primate models for Ebola virus infections, which closely resemble disease progression in humans. Though these vaccine platforms seem to confer protection through different mechanisms, several of them are efficacious against lethal disease in nonhuman primates attesting that vaccination against Ebola virus infections is feasible. Twit Text FOAVip Ebola virus vaccines: an overview of current approaches ????Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=24575870 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24575870 #FOAvip English Wikipedia <ref>{{Cite pmid|24575870}}</ref> Ebola virus vaccines: an overview of current approaches #MMPMID24575870 Marzi A; Feldmann H Expert Rev Vaccines 2014[Apr]; 13 (4): 521-31 PMID24575870show ga Ebola hemorrhagic fever is one of the most fatal viral diseases worldwide affecting humans and nonhuman primates. Although infections only occur frequently in Central Africa, the virus has the potential to spread globally and is classified as a category A pathogen that could be misused as a bioterrorism agent. As of today there is no vaccine or treatment licensed to counteract Ebola virus infections. DNA, subunit and several viral vector approaches, replicating and non-replicating, have been tested as potential vaccine platforms and their protective efficacy has been evaluated in nonhuman primate models for Ebola virus infections, which closely resemble disease progression in humans. Though these vaccine platforms seem to confer protection through different mechanisms, several of them are efficacious against lethal disease in nonhuman primates attesting that vaccination against Ebola virus infections is feasible. äEbola virus vaccines: an overview of current approaches (epmc).pdf DeepDyve Pubget Overpricing